Standard

Protein modification by thiolactone homocysteine chemistry : A multifunctionalized human serum albumin theranostic. / Popova, Tatyana V.; Krumkacheva, Olesya A.; Burmakova, Anna S. et al.

In: RSC Medicinal Chemistry, Vol. 11, No. 11, 02.04.2020, p. 1314-1325.

Research output: Contribution to journalArticlepeer-review

Harvard

Popova, TV, Krumkacheva, OA, Burmakova, AS, Spitsyna, AS, Zakharova, OD, Lisitskiy, VA, Kirilyuk, IA, Silnikov, VN, Bowman, MK, Bagryanskaya, EG & Godovikova, TS 2020, 'Protein modification by thiolactone homocysteine chemistry: A multifunctionalized human serum albumin theranostic', RSC Medicinal Chemistry, vol. 11, no. 11, pp. 1314-1325. https://doi.org/10.1039/c9md00516a

APA

Popova, T. V., Krumkacheva, O. A., Burmakova, A. S., Spitsyna, A. S., Zakharova, O. D., Lisitskiy, V. A., Kirilyuk, I. A., Silnikov, V. N., Bowman, M. K., Bagryanskaya, E. G., & Godovikova, T. S. (2020). Protein modification by thiolactone homocysteine chemistry: A multifunctionalized human serum albumin theranostic. RSC Medicinal Chemistry, 11(11), 1314-1325. https://doi.org/10.1039/c9md00516a

Vancouver

Popova TV, Krumkacheva OA, Burmakova AS, Spitsyna AS, Zakharova OD, Lisitskiy VA et al. Protein modification by thiolactone homocysteine chemistry: A multifunctionalized human serum albumin theranostic. RSC Medicinal Chemistry. 2020 Apr 2;11(11):1314-1325. doi: 10.1039/c9md00516a

Author

BibTeX

@article{d460d0eb1d964d0bac761f8579b0d0b9,
title = "Protein modification by thiolactone homocysteine chemistry: A multifunctionalized human serum albumin theranostic",
abstract = "As the most abundant protein with a variety of physiological functions, albumin has been used extensively for the delivery of therapeutic molecules. Thiolactone chemistry provides a powerful tool to prepare spin-labeled albumin-based multimodal imaging probes and therapeutic agents. We report the synthesis of a tamoxifen homocysteine thiolactone derivative and its use in thiol-'click' chemistry to prepare multi-functionalized serum albumin. The released sulfhydryl group of the homocysteine functional handle was labeled with a nitroxide reagent to prepare a spin-labeled albumin-tamoxifen conjugate confirmed by MALDI-TOF-MS, EPR spectroscopy, UV-vis and fluorescent emission spectra. This is the basis for a novel multimodal tamoxifen-albumin theranostic with a significant (dose-dependent) inhibitory effect on the proliferation of malignant cells. The response of human glioblastoma multiforme T98G cells and breast cancer MCF-7 cells to tamoxifen and its albumin conjugates was different in tumor cells with different expression level of ERα in our experiments. These results provide further impetus to develop a serum protein for delivery of tamoxifen to cancer cells. ",
keywords = "IN-VIVO, FC-RECEPTOR, SPIN-LABEL, HALF-LIFE, CONFORMATIONAL-CHANGES, FUNCTIONAL IMPAIRMENT, VERSATILE PLATFORM, CLICK CHEMISTRY, DRUG-DELIVERY, TAMOXIFEN",
author = "Popova, {Tatyana V.} and Krumkacheva, {Olesya A.} and Burmakova, {Anna S.} and Spitsyna, {Anna S.} and Zakharova, {Olga D.} and Lisitskiy, {Vladimir A.} and Kirilyuk, {Igor A.} and Silnikov, {Vladimir N.} and Bowman, {Michael K.} and Bagryanskaya, {Elena G.} and Godovikova, {Tatyana S.}",
note = "Publisher Copyright: {\textcopyright} 2020 The Royal Society of Chemistry. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2020",
month = apr,
day = "2",
doi = "10.1039/c9md00516a",
language = "English",
volume = "11",
pages = "1314--1325",
journal = "RSC Medicinal Chemistry",
issn = "2632-8682",
publisher = "Royal Society of Chemistry",
number = "11",

}

RIS

TY - JOUR

T1 - Protein modification by thiolactone homocysteine chemistry

T2 - A multifunctionalized human serum albumin theranostic

AU - Popova, Tatyana V.

AU - Krumkacheva, Olesya A.

AU - Burmakova, Anna S.

AU - Spitsyna, Anna S.

AU - Zakharova, Olga D.

AU - Lisitskiy, Vladimir A.

AU - Kirilyuk, Igor A.

AU - Silnikov, Vladimir N.

AU - Bowman, Michael K.

AU - Bagryanskaya, Elena G.

AU - Godovikova, Tatyana S.

N1 - Publisher Copyright: © 2020 The Royal Society of Chemistry. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2020/4/2

Y1 - 2020/4/2

N2 - As the most abundant protein with a variety of physiological functions, albumin has been used extensively for the delivery of therapeutic molecules. Thiolactone chemistry provides a powerful tool to prepare spin-labeled albumin-based multimodal imaging probes and therapeutic agents. We report the synthesis of a tamoxifen homocysteine thiolactone derivative and its use in thiol-'click' chemistry to prepare multi-functionalized serum albumin. The released sulfhydryl group of the homocysteine functional handle was labeled with a nitroxide reagent to prepare a spin-labeled albumin-tamoxifen conjugate confirmed by MALDI-TOF-MS, EPR spectroscopy, UV-vis and fluorescent emission spectra. This is the basis for a novel multimodal tamoxifen-albumin theranostic with a significant (dose-dependent) inhibitory effect on the proliferation of malignant cells. The response of human glioblastoma multiforme T98G cells and breast cancer MCF-7 cells to tamoxifen and its albumin conjugates was different in tumor cells with different expression level of ERα in our experiments. These results provide further impetus to develop a serum protein for delivery of tamoxifen to cancer cells.

AB - As the most abundant protein with a variety of physiological functions, albumin has been used extensively for the delivery of therapeutic molecules. Thiolactone chemistry provides a powerful tool to prepare spin-labeled albumin-based multimodal imaging probes and therapeutic agents. We report the synthesis of a tamoxifen homocysteine thiolactone derivative and its use in thiol-'click' chemistry to prepare multi-functionalized serum albumin. The released sulfhydryl group of the homocysteine functional handle was labeled with a nitroxide reagent to prepare a spin-labeled albumin-tamoxifen conjugate confirmed by MALDI-TOF-MS, EPR spectroscopy, UV-vis and fluorescent emission spectra. This is the basis for a novel multimodal tamoxifen-albumin theranostic with a significant (dose-dependent) inhibitory effect on the proliferation of malignant cells. The response of human glioblastoma multiforme T98G cells and breast cancer MCF-7 cells to tamoxifen and its albumin conjugates was different in tumor cells with different expression level of ERα in our experiments. These results provide further impetus to develop a serum protein for delivery of tamoxifen to cancer cells.

KW - IN-VIVO

KW - FC-RECEPTOR

KW - SPIN-LABEL

KW - HALF-LIFE

KW - CONFORMATIONAL-CHANGES

KW - FUNCTIONAL IMPAIRMENT

KW - VERSATILE PLATFORM

KW - CLICK CHEMISTRY

KW - DRUG-DELIVERY

KW - TAMOXIFEN

UR - http://www.scopus.com/inward/record.url?scp=85096512911&partnerID=8YFLogxK

U2 - 10.1039/c9md00516a

DO - 10.1039/c9md00516a

M3 - Article

C2 - 34085043

AN - SCOPUS:85096512911

VL - 11

SP - 1314

EP - 1325

JO - RSC Medicinal Chemistry

JF - RSC Medicinal Chemistry

SN - 2632-8682

IS - 11

ER -

ID: 26134874